Results 141 to 150 of about 46,694 (224)

Molecular epidemiology and increasing macrolide resistance of Bordetella pertussis isolates in Guangzhou, China. [PDF]

open access: yesBMC Infect Dis
Mai Q   +17 more
europepmc   +1 more source

Molecular epidemiology and genomic features of Bordetella pertussis in Tianjin, China, 2023. [PDF]

open access: yesBMC Microbiol
Lu X   +9 more
europepmc   +1 more source

Draft genome sequence of <i>Bordetella pertussis</i> PS21, a circulating clinical isolate from India. [PDF]

open access: yesMicrobiol Resour Announc
Irulappan M   +7 more
europepmc   +1 more source

Limited response of primary nasal epithelial cells to <i>Bordetella pertussis</i> infection. [PDF]

open access: yesMicrobiol Spectr
Zmuda M   +5 more
europepmc   +1 more source

Seroprevalence of <i>Bordetella pertussis</i> in patients with COPD in a UK cohort. [PDF]

open access: yesERJ Open Res
Richardson H   +5 more
europepmc   +1 more source

A model based evaluation of the 1996-7 pertussis epidemic in the Netherlands [PDF]

open access: yes, 2001
Boven, M., van   +3 more
core   +2 more sources

Comparing Respiratory Illness Surveillance Case Definitions to Detect Bordetella pertussis in Children Aged <5 Years With Respiratory Illness in South Africa, 2017-2023. [PDF]

open access: yesJ Infect Dis
Bishop K   +15 more
europepmc   +1 more source

An endogenous human peptide derived from α<sub>1</sub>-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin. [PDF]

open access: yesNaunyn Schmiedebergs Arch Pharmacol
Lietz S   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy